{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T18:11:45Z","timestamp":1794679905297,"version":"4.9.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":3360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.jpainsymman.2010.02.007","type":"journal-article","created":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T04:31:07Z","timestamp":1276489867000},"page":"783-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Sublingual Atropine Drops for the Treatment of Pediatric Sialorrhea"],"prefix":"10.1016","volume":"40","author":[{"given":"Adam","family":"Rapoport","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2010.02.007_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ijporl.2005.07.021","article-title":"Saliva control issues in the neurologically challenged. A\u00a030 year experience in team management","volume":"70","author":"Crysdale","year":"2006","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0165-5876(92)90067-Y","article-title":"Swallowing disorders in a population of children with cerebral palsy","volume":"24","author":"Waterman","year":"1992","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1469-8749.2000.tb00678.x","article-title":"Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study","volume":"42","author":"Sullivan","year":"2000","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib4","first-page":"2628","article-title":"Sialorrhea: a management challenge","volume":"69","author":"Hockstein","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MOO.0b013e328011014a","article-title":"Drooling","volume":"14","author":"Lal","year":"2006","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1071-9091(03)00072-X","article-title":"Management of drooling","volume":"10","author":"Brei","year":"2003","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tripleo.2005.08.018","article-title":"Drooling of saliva: a review of the etiology and management options","volume":"101","author":"Meningaud","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1469-8749.1990.tb16946.x","article-title":"A survey of signs, symptoms and symptom control in 30 terminally ill children","volume":"32","author":"Hunt","year":"1990","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11060-008-9670-x","article-title":"End of life issues in brain tumor patients","volume":"91","author":"Pace","year":"2009","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib10","doi-asserted-by":"crossref","first-page":"e1179","DOI":"10.1542\/peds.2005-0683","article-title":"Symptoms in children\/young people with progressive malignant disease: United Kingdom Children's Cancer Study Group\/Paediatric Oncology Nurses Forum survey","volume":"117","author":"Goldman","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1469-8749.2001.tb00225.x","article-title":"Management of drooling in individuals with neurodisability: a surgical experience","volume":"43","author":"Crysdale","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib12","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.prs.0000182221.11733.12","article-title":"Prospective analysis of the outcome of surgical management of drooling in the pediatric population: a 10-year experience","volume":"116","author":"Greensmith","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/adc.2005.084681","article-title":"Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy?","volume":"91","author":"Vaile","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1542\/peds.2003-1104-L","article-title":"Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial","volume":"114","author":"Jongerius","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/adc.88.10.911","article-title":"A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling","volume":"88","author":"Jongerius","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1469-8749.2002.tb00286.x","article-title":"Management of drooling: 10 years after the Consortium on Drooling, 1990","volume":"44","author":"Blasco","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1177\/0269216306071702","article-title":"Atropine drops for drooling: a randomized controlled trial","volume":"20","author":"De Simone","year":"2006","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib18","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1345\/aph.1E077","article-title":"Intraoral application of atropine sulfate ophthalmic solution for clozapine-induced sialorrhea","volume":"38","author":"Sharma","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib19","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1080\/000486700285","article-title":"Use of atropine eye drops for clozapine induced hypersalivation","volume":"34","author":"Comley","year":"2000","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/mds.10276","article-title":"Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study","volume":"17","author":"Hyson","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib21","first-page":"253","article-title":"Clozapine and sialorrhea: update","volume":"26","author":"Tessier","year":"2001","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib22","first-page":"250","article-title":"Clozapine and sialorrhea: a new intervention for this bothersome and potentially dangerous side effect","volume":"24","author":"Antonello","year":"1999","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2044.1957.tb03615.x","article-title":"Antisialogogue drugs in man; comparison of atropine, scopolamine (1-hyoscine) and 1-hyoscyamine (bellafoline)","volume":"12","author":"Wyant","year":"1957","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/014107688007301008","article-title":"Comparison of the effects of atropine and glycopyrrolate on various end-organs","volume":"73","author":"Mirakhur","year":"1980","journal-title":"J R Soc Med"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib25","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1345\/aph.1C019","article-title":"Sialorrhea\u2014therapeutic drug options","volume":"36","author":"Tscheng","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib26","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/000992289803700805","article-title":"Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy","volume":"37","author":"Bachrach","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib27","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archpedi.154.12.1214","article-title":"Treatment of sialorrhea with glycopyrrolate: a double-blind, dose-ranging study","volume":"154","author":"Mier","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1399-6576.1988.tb02691.x","article-title":"Pharmacokinetic implications for the clinical use of atropine, scopolamine and glycopyrrolate","volume":"32","author":"Kanto","year":"1988","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpedi.1996.02170340046009","article-title":"Glycopyrrolate treatment of chronic drooling","volume":"150","author":"Blasco","year":"1996","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1469-8749.1994.tb11877.x","article-title":"Transdermal scopolamine for reduction of drooling in developmentally delayed children","volume":"36","author":"Lewis","year":"1994","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib31","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1542\/peds.97.1.126","article-title":"Esotropia in a child treated with a scopolamine patch for drooling","volume":"97","author":"Good","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib32","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1469-8749.1991.tb14818.x","article-title":"Control of drooling with transdermal scopolamine in a child with cerebral palsy","volume":"33","author":"Siegel","year":"1991","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib33","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(86)92633-4","article-title":"Toxic psychosis from transdermal scopolamine in a child","volume":"2","author":"Sennhauser","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-8749.1989.tb04000.x","article-title":"Efficacy of benztropine therapy for drooling","volume":"31","author":"Camp-Bruno","year":"1989","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00004356-199206000-00011","article-title":"Management of drooling in cerebral palsy: three single case studies","volume":"15","author":"Owen","year":"1992","journal-title":"Int J Rehabil Res"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000104540","article-title":"Management of non-pain symptoms in pediatric palliative care","volume":"16","author":"Friedrichsdorf","year":"2007","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2146\/ajhp080194","article-title":"Anticholinergic medications for managing noisy respirations in adult hospice patients","volume":"66","author":"Kintzel","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jpainsymman.2008.07.007","article-title":"Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care","volume":"38","author":"Wildiers","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1272\/jnms.74.50","article-title":"Intravenous atropine treatment in hypertrophic pyloric stenosis: evaluation by clinical course and imaging","volume":"74","author":"Asai","year":"2007","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib40","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00383-006-1751-3","article-title":"Conservative treatment of infantile hypertrophic pyloric stenosis with intravenous atropine sulfate does not replace pyloromyotomy","volume":"22","author":"Meissner","year":"2006","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib41","first-page":"172","article-title":"Management and ultrasonographic appearance of infantile hypertrophic pyloric stenosis with intravenous atropine sulfate","volume":"23","author":"Nagita","year":"1996","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1460-9592.1997.d01-40.x","article-title":"Plasma concentration following oral and intramuscular atropine in children and their clinical effects","volume":"7","author":"Gervais","year":"1997","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1399-6576.1985.tb02248.x","article-title":"Comparison of pharmacokinetic and pharmacodynamic parameters following oral or intramuscular atropine in children. Atropine overdose in two small children","volume":"29","author":"Saarnivaara","year":"1985","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib44","series-title":"Pediatric dosage handbook","author":"Taketomo","year":"2006"},{"key":"10.1016\/j.jpainsymman.2010.02.007_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00192357","article-title":"Comparison of the effects of atropine in vivo and ex vivo (radioreceptor assay) after oral and intramuscular administration to man","volume":"49","author":"Volz-Zang","year":"1995","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392410003131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392410003131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:04:18Z","timestamp":1760130258000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392410003131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0885392410003131"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.02.007","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sublingual Atropine Drops for the Treatment of Pediatric Sialorrhea","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2010.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}